Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
Raboud JM, Montaner JS, Conway B, Rae S, Reiss P, Vella S, Cooper D, Lange J, Harris M, Wainberg MA, Robinson P, Myers M, Hall D.
Raboud JM, et al. Among authors: conway b.
AIDS. 1998 Sep 10;12(13):1619-24. doi: 10.1097/00002030-199813000-00008.
AIDS. 1998.
PMID: 9764780
Clinical Trial.